Management of refractory ascites attenuates muscle mass reduction and improves survival in patients...
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis
About this item
Full title
Author / Creator
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
Background
This study investigated time-course changes in skeletal muscle volume per year with tolvaptan in patients with refractory ascites that was unresponsive to loop diuretics and aldosterone antagonists.
Methods
This retrospective study included 42 patients who received tolvaptan for refractory ascites and/or hepatic edema and underw...
Alternative Titles
Full title
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2285109188
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2285109188
Other Identifiers
ISSN
0944-1174
E-ISSN
1435-5922
DOI
10.1007/s00535-019-01623-4
